Servier is an international pharmaceutical company governed by a non-profit Foundation and headquartered in France.
With a strong international presence in 148 countries and a turnover of 4 billion euros in 2016, we employ over 21,000 people worldwide and more than 2,000 in R&D, in Paris area.
Being completely independent, we reinvest 25% of turnover (excluding generics) in Research and Development and use all our profits in growth.
We are specialized and driven by our constant search for innovation in five major research areas: cardiovascular diseases, cancers, diabetes, immuno-inflammatory diseases and neurodegenerative diseases, as well as by our activities in high-quality generic drugs.
At Servier we continue to foster the ambition to provide innovative therapies for unmet medical needs for the benefit of patients. We are a key player in cardiology and hypertension for the last 20 years, number 2 in Europe and 8 worldwide.
Poste et missions
We are now recruiting a:
Post doctoral position – Deep Learning for High Content Screening
As a Postdoctoral Researcher, you will Implement and deploy Deep Learning strategy for high content screening to support drug discovery activities.
You will focus on building Deep Learning understandability approaches
- Ph.D. in Image Analysis, Machine Learning-related field
- Previous experience in Convolutional neural network implementation
- Image processing and machine learning
- Development skills required (C#, Python, deep learning libraries)
- Ability to work in a multidisciplinary team
- Scientific rigor and creativity
- French is a plus, English is mandatory
Joining Servier means working in a stimulating environment and contributing to an innovative, research-based and people-oriented organization.
Servier is the leading French independent pharmaceutical company, located in 144 countries with 21 000 employees and a turnover in 2015 of about 4 billion euros.
25% of Servier’s annual turnover is reinvested in Research & Development, reflecting the company’s dedication to its mission of innovation and discovery for improved treatment of unmet medical needs.
Organized as a foundation, we guarantee our independence from the stock exchange. As our late founder Doctor Jacques Servier said: “a company is a group of human beings, so it has no price”.
Servier is well known for its attention to the wellbeing of the staff, with particular importance placed on career evolution within the Group, and to an agreeable and productive working environment.
To know more, visit www.servier.com